Absci Corporation
$5.94
-6.5%Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -7.1).
Valuation inputs: P/E -7.1, earnings yield N/A, momentum -6.5%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -60.8%, ROIC -63.6%).
Profitability stack: net margin -41.1%, ROE -60.8%, ROIC -63.6%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +12.4%, momentum -6.5%, net margin -41.1%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Absci Corporation Market vs Earnings Trajectory
Performance Analysis
EPS Growth
Positive earnings growth shows the company is improving its profitability over time.
Price-EPS Relationship
Stock price is moving in line with earnings growth—a healthy sign of fundamental-driven valuation.
Stock Price Change
Over the 1Y period, stock price has increased by 108.4%.
P/E Ratio (TTM)
Relatively low P/E may indicate undervaluation or lower growth expectations.
Key Insight
With growing earnings (+11.7%) and a relatively low P/E ratio (-7.1x), the stock may be undervalued if the growth trend continues.
Absci Corporation Fair Value Envelope
Absci Corporation Profit Bridge
Profitability Analysis
Gross Margin
Negative gross margin indicates the company is losing money on each sale—unsustainable long-term.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
Absci Corporation Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Absci Corporation Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Financial Health Insight
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
Absci Corporation Street Expectations Map
Wall Street analysts project that ABSI stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 7.03, with estimates ranging from a low of 4.10 to a high of 9.00.
The consensus 1-year price target stands at 7.03, with estimates ranging from a low of 4.10 to a high of 9.00.
Analyst Consensus Analysis
Upside Potential
Strong upside potential. Consensus indicates attractive return opportunity with favorable risk-reward profile.
Analyst Agreement
High uncertainty. Very wide target spread indicates significant disagreement among analysts—major valuation uncertainty or transformation underway.
Risk-Reward Profile
Balanced risk-reward. Upside and downside potential relatively symmetric. Suitable for moderate risk tolerance with conviction in thesis.
Analyst Conviction
High uncertainty: Wide dispersion indicates analysts struggle to agree on valuation—proceed with caution and independent analysis.
Market Sentiment Insight
High risk, high reward: Substantial upside potential exists, but wide analyst disagreement signals execution risk or unclear catalysts. Thorough due diligence essential before committing capital.
Absci Corporation Insider Positioning
During the last 12 months, insiders have purchased $1.68M and sold $332K worth of ABSI shares, resulting in $1.35M of net buying activity.
3 Months
137.5K
429.75K
0
0.00
+430K
+$430K
3-6 Months
75.1K
205.76K
44.3K
132.33K
+73K
+$73K
6-9 Months
145.8K
430.59K
48.7K
179.30K
+251K
+$251K
9-12 Months
228.4K
612.27K
8.3K
19.88K
+592K
+$592K
Top Buyers
Pangalos Menelas N
Director
$661K
Szela Mary T
Director
$460K
Busch Andreas
Officer: Chief Innovation Officer
$381K
Van Houten Frans
Director
$149K
Bedrick Todd
Officer: Svp, Cao
$27K
Top Sellers
Mcclain Sean
Director, Officer: Chief Executive Officer
$166K
Bedrick Todd
Officer: Svp, Cao
$81K
Jonasson Zachariah
Officer: Cfo / Cbo
$74K
Busch Andreas
Officer: Chief Innovation Officer
$11K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $1.35M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
5 insider buyers vs. 4 sellers. More insiders buying than selling indicates positive sentiment.
Insider Activity Insight
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
No Dividend Yield Data
ABSI has not reported any dividend yield values in the available annual periods.
absi Dividend History
Learning Layer
Related Guides
Build conviction on ABSI by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.